In our latest News and Views: Charlotte Sumner and Thomas O. Crawford HopkinsMedicine discuss implications of the phase 3 SPR1NT trial, in which pre-symptomatic genetherapy demonstrated impressive outcomes in infants with spinal muscular atrophy SMA
Onasemnogene abeparvovec is an in vivo viral-mediated gene therapy — one of only two such therapies in clinical use — which is approved for one-time intravenous administration to infants under 2 years of age with spinal muscular atrophy . Despite the small number of in vivo gene therapies in clinical use, more than a hundred are in clinical trials .
The greatest benefit from these rapidly emerging treatments is likely to come when initiated prior to disease onset, particularly when disease progression claims non-replicating cells such as neurons — as is the case for SMA. In paired papers in this issue of, Strauss et al.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
MLB Draft: Standout Palo Alto outfielder taken by A’s in second roundPaly’s Henry Bolte goes to the Oakland A’s in the second round at No. 56 overall.
Weiterlesen »
Last maternity clinic in Ukraine-controlled Donbas a lifeline as war closes inThe last maternity clinic in Ukraine-controlled Donbas is a lifeline as war closes in.
Weiterlesen »
Oakland A’s prospect Langeliers wins Futures Game MVP; HR, nails runner in AL winOakland A’s prospect Shea Langeliers is headed to the Hall of Fame, even before his big league debut.
Weiterlesen »
MLB Draft: Oakland A’s take NorCal native at No. 19 overallOakland A’s, with three picks on the first day of the MLB Draft, select catcher Daniel Susac from the University of Arizona with the 19th overall selection
Weiterlesen »
Astros fall to A's in final game before All-Star breakA cascade of poor pitches and defensive mistakes erased the Astros' three-run lead in one wretched inning.
Weiterlesen »
‘Mathematics is an unknown land’: meet Fields Medal winner Maryna ViazovskaNature talks to the Ukrainian mathematician about her research and how the field is changing.
Weiterlesen »